Is serum 25-hydroxyvitamin D levels associated with severity of COVID-19 disease? A retrospective study
M. Hunziker (Basel, Switzerland), K. Abig (Liestal, Switzerland), M. Bösing (Liestal, Switzerland), S. Giezendanner (Basel, Switzerland), F. Jaun (Liestal, Switzerland), G. Lüthi-Corridori (Liestal, Switzerland), A. Makhdoomi (Liestal, Switzerland), J. Muser (Liestal, Switzerland), J. Leuppi (Liestal, Switzerland)
Source: International Congress 2022 – Biomarkers in COVID
Session: Biomarkers in COVID
Session type: Thematic Poster
Number: 344
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Hunziker (Basel, Switzerland), K. Abig (Liestal, Switzerland), M. Bösing (Liestal, Switzerland), S. Giezendanner (Basel, Switzerland), F. Jaun (Liestal, Switzerland), G. Lüthi-Corridori (Liestal, Switzerland), A. Makhdoomi (Liestal, Switzerland), J. Muser (Liestal, Switzerland), J. Leuppi (Liestal, Switzerland). Is serum 25-hydroxyvitamin D levels associated with severity of COVID-19 disease? A retrospective study. 344
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|